Showing posts with label Nano Technology. Show all posts
Showing posts with label Nano Technology. Show all posts

AMD Split Violates License Agreement

Intel Says AMD Split Violates License Agreement

http://www.aurorawdc.com/ci/amd_vs_intel_2.jpg

AMD and Intel are rivals in the marketplace when it comes to x86 compatible CPUs and graphics processors. AMD and Intel have a cross-license agreement in place that allow AMD to use Intel IP to build x86 compatible processors.

On October 7, AMD announced that it was splitting its holdings into two separate companies. AMD will continue as a designer of CPUs and GPUs. The other company is called The Foundry and will be responsible for manufacturing chips for AMD and other companies.

The new company starts with AMD's chip fabs and the chipmaker will retain a 44.4% stake in The Foundry. The remaining 55.6% of The Foundry will be owned by a pair of Abu Dhabi companies that together invested $5.7 billion.

BetaNews reports that Intel issued a statement saying that it will be investigating whether or not the split of AMD and AMD's resulting minority stake in The Foundry violates the heavily redacted licensing agreement that allows AMD to design and manufacture x86 compatible CPUs.

Intel's Chuck Malloy told BetaNews, "We have an obligation to our shareholders that we protect our intellectual property. We want to make sure their interests have been taken into consideration."

AMD for its part believes that it is not in violation of licensing agreements in place between it and Intel. AMD's Michael Silverman told BetaNews, "We are completely confident the structure of this transaction takes into account our cross-license agreements. Rest assured, we plan to continue respecting Intel's intellectual property rights, just as we expect them to respect ours."

According to eWeek, Hans Mosesmann, a financial analyst with Raymond James, believes that Intel could use the split of AMD and transfer of its IP to The Foundry to pressure AMD to drop long-standing lawsuits it has against Intel.

Mosesmann wrote, "AMD, in our view, is likely violating the Intel x86 cross-license, but we suspect Intel may look the other way as it benefits Intel to have an AMD that will over time have increasing variable costs (good for ASPs). Intel may choose to entice AMD to drop the anti-trust suits against Intel in return for this altruistic gesture.”

It appears that Intel is pressuring AMD to release a non-redacted version of the licensing agreement to the public, at this point only the heavily redacted version is available. AMD maintains that releasing a non-redacted version of the license agreement is not going to happen.

AMD spokesman Phil Hughes said, "It’s a business document and we are not going to negotiate this in the press or the media. This is something that the lawyers have to work out.

Nanosensor Detects Immune Cell Signals

Nanosensor Detects Immune Cell Signals; Could Fight AIDS, Cancer

The Scientists have developed nanomachines which have targeted cancer cells delivering deadly poisons to kill them, without harming any healthy cells. However, the key to nano drugs is not merely their creation, but their targeting factors.

The research was funded by grants from the Defense Advanced Research Projects Agency, Air Force Office of Scientific Research, the National Institutes of Health, the Vanderbilt Institute for Integrative Biosystems Research and Education and the Systems Biology and Bioengineering Undergraduate Research Experience.

In the body cells can signaling in multiple ways. Some of the cells send signals to adjacent cells -- this method is very detectable and is also well documented. Sometimes cells send long distance chemical messengers in the blood stream, such as adrenaline. These signals are also readily detectable. However, a great deal of the body's signaling is thought to occur at short distances between non-connected cells, known as paracrine signaling. Paracrine signaling is one of the least understood fields of physiology and just recently have scientists begun to recognize it's great significance.

Discovery of paracrine signaling, which is detailed in the journal Lab On A Chip. The MTN was revolutionary in that it could detect minute quantities of paracrine chemicals, previously too dilute to be detected. Now the researchers have developed a more advanced sensor which pumps cells into the MTN sensor, which traps and cultures them. The new sensor monitors the trapped cells with a variety of digital and chemical methods to better understand the paracrine signaling. This is really cool invention.

Co-author Derya Unutmaz, now an associate professor of microbiology at New York University's School of Medicine stated, "This is an important advance and potentially very useful technology. The ability to study the behavior of single cells may not be as critical if you are studying the heart or muscles, which are mostly formed by uniform cells, but it is crucial for understanding how the immune system functions. The wide surveillance of the body that it conducts requires extensive communication between dozens of different kinds of immune cells."

Generally the immune system has stored T Cells in the lymph nodes. When a dendritic cells sense an invader -- such as the Flu virus, a cancer cell, or the AIDS virus -- it signals T Cells to make preparations to the fight the intruder. As only a certain percentage of T Cells are tuned to fight each type of intruder, the dendritic cells must properly recruit the right candidates for the job out of millions of cells, a daunting process that previously was a mystery.

Using plastic microfluid channels smaller than a human hair, cells and culture media is pumped into the nanodevice, molded into the bottom of a glass microscope cover slip. In a special chamber cells are caught in special wells. Fluid flows out holes in the bottoms of the wells, passively trapping the cells. Thanks to the media they can be kept alive 24 hours or more, longer than normal.

A digital camera monitors the cells, snapping pictures every 30 seconds. Software analyzes the cells actions. In the presence of certain activity indicators such as calcium, phosphorescent dye lights up brightly.

Graduate student Shannon Faley, now a postdoctoral research associate at the University of Glasgow, Scotland was the first to notice paracrine signaling occurring. She used an MTN with trapped dendritic cells. She noticed that the mature dendritic cells signaled some naive T cells that they were in contact with. However, they also somehow signaled the correct T Cells downstream as well. She described, "My reaction when I saw them was, 'What in the world is going on?'"

Professor Wikswo further added, "When she saw this, Shannon did a very clever thing. She took one chamber and filled it with dendritic cells and took a second chamber and filled it with T-cells. Then she hooked the second chamber downstream of the first."

The cells in the second chamber reacted, indicating undeniable presence of a great chemical agent. While researchers still have not identified the precise chemical agent, or what its exact function is, they hope to find that out early.

Researchers plan to look at paracrine responses to tumor cells, AIDS, and other deadly diseases. Based on studying how the immune system works and what "goes wrong" in severe cases like AIDS, better defenses can be developed.The signaling between cancer cells can also be isolated and be used to target them.

Dana Marshall, associate professor at the Meharry Medical College, and Professor Wikswo have already submitted a proposal to use the device to study triple-negative breast tumors, one of the most deadly forms of breast cancer.

Some cancers such as the aforementioned one respond to chemotherapy for a time and then become immune. Dr. Marshall stated, "Often, when therapy fails, the tumor responds to a chemotherapy treatment for a period of time and then it stops. This approach may let us figure out why that happens."

The new device was developed by a research team at the Vanderbilt Institute for Integrative Biosystems Research and Education headed by John P. Wikswo, the Gordon A. Cain University Professor at Vanderbilt. The device has already provided a never-before-seen glimpse at how dendritic cells (a type of white blood cell) in the immune system signal T-Cells (another type of white blood cell) to destroy infection.

powered by Blogger | WordPress by Newwpthemes | Converted by BloggerTheme